PsyRX CNS Bio-Tech Ltd (TLV:PSRX)
116.30
-6.30 (-5.14%)
At close: Feb 25, 2026
PsyRX CNS Bio-Tech Company Description
PsyRX CNS Bio-Tech Ltd engages in developing cannabinoid-based medication and healthcare products.
It provides drugs for various indications; personalized cannabinoid-based products; and CBD-based skincare and food-supplement products.
PsyRX CNS Bio-Tech Ltd was formerly known as Cannabotech LTD. The company was incorporated in 2019 and is based in Rishon LeZion, Israel.
PsyRX CNS Bio-Tech Ltd
| Country | Israel |
| Founded | 2019 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Itay Hecht |
Contact Details
| Phone | 972 5 44988960 |
| Website | psyrx.co |
Stock Details
| Ticker Symbol | PSRX |
| Exchange | Tel Aviv Stock Exchange |
| Reporting Currency | ILS |
| ISIN Number | IL0011769085 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Itay Hecht | Chief Executive Officer |